Skip to main content
logo
Clywedog Therapeutics, Inc. (CLYD)
0.00
0.00 (0.00%)
No quote available

Clywedog Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
FY 2025
Period Ending
Dec '25
Cash & Equivalents
0.22
Cash & Short-Term Investments
0.22
Cash Growth
-
Prepaid Expenses
3.07
Total Current Assets
3.29
Other Long-Term Assets
0.73
Total Assets
4.02

Liabilities

Fiscal Year
FY 2025
Period Ending
Dec '25
Accounts Payable
0.91
Accrued Expenses
4.56
Total Current Liabilities
5.48
Long-Term Debt
1.48
Other Long-Term Liabilities
20.35
Total Liabilities
27.3

Shareholders' Equity

Fiscal Year
FY 2025
Period Ending
Dec '25
Retained Earnings
-36.06
Total Common Equity
-36.06
Shareholders' Equity
-23.28
Total Liabilities & Equity
4.02

Additional Metrics

Fiscal Year
FY 2025
Period Ending
Dec '25
Total Debt
1.48
Net Cash (Debt)
-1.26
Net Cash Growth
-
Net Cash Per Share
-0.83
Filing Date Shares Outstanding
40.85
Total Common Shares Outstanding
40.85
Working Capital
-2.18
Book Value Per Share
-0.88
Tangible Book Value
-36.06
Tangible Book Value Per Share
-0.88